NEXGEL, INC. (NXGL) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Win.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Win; EPS growth Lose.
28/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 3 wins, 9 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
LoseNXGL / S&P -20.85% / 15.20% |
LoseNXGL / S&P 3.38% / 15.00% |
WinNXGL / S&P 77.50% / 50.40% |
| 2026-Q10/3 |
LoseNXGL / S&P -60.68% / -4.33% |
LoseNXGL / S&P 10.14% / 11.30% |
LoseNXGL / S&P -11.11% / 27.70% |
| 2025-Q41/3 |
LoseNXGL / S&P -34.02% / 2.65% |
WinNXGL / S&P 31.46% / 9.00% |
LoseNXGL / S&P -24.00% / 13.40% |
| 2025-Q31/3 |
LoseNXGL / S&P -5.43% / 8.12% |
WinNXGL / S&P 73.38% / 4.61% |
LoseNXGL / S&P -37.29% / 13.45% |
| 2025-Q21/3 |
LoseNXGL / S&P -13.42% / 10.94% |
WinNXGL / S&P 133.00% / 4.83% |
LoseNXGL / S&P -31.03% / 10.63% |
| 2025-Q11/3 |
LoseNXGL / S&P -33.18% / -4.27% |
WinNXGL / S&P 115.94% / 4.98% |
LoseNXGL / S&P -19.64% / 10.57% |
| 2024-Q42/3 |
WinNXGL / S&P 72.87% / 2.41% |
WinNXGL / S&P 112.40% / 5.25% |
LoseNXGL / S&P -12.28% / 6.15% |
| 2024-Q33/3 |
WinNXGL / S&P 19.44% / 5.89% |
WinNXGL / S&P 90.49% / 5.89% |
WinNXGL / S&P 22.92% / 6.11% |
| 2024-Q21/3 |
LoseNXGL / S&P -20.88% / 4.28% |
WinNXGL / S&P 73.98% / 5.38% |
LoseNXGL / S&P -3.33% / 5.12% |
| 2024-Q12/3 |
WinNXGL / S&P 28.17% / 10.56% |
WinNXGL / S&P 108.36% / 5.71% |
LoseNXGL / S&P -16.42% / 5.59% |
| 2023-Q41/3 |
LoseNXGL / S&P 0.47% / 11.69% |
WinNXGL / S&P 99.61% / 6.81% |
LoseNXGL / S&P -32.94% / 7.78% |
| 2023-Q31/3 |
LoseNXGL / S&P -15.27% / -3.27% |
WinNXGL / S&P 71.62% / 7.52% |
LoseNXGL / S&P -62.50% / -5.03% |
| 2023-Q22/3 |
WinNXGL / S&P 95.47% / 8.74% |
WinNXGL / S&P 57.75% / 9.50% |
LoseNXGL / S&P -58.33% / -8.57% |
| 2023-Q11/3 |
LoseNXGL / S&P 2.40% / 7.50% |
WinNXGL / S&P 35.22% / 10.77% |
LoseNXGL / S&P -56.21% / -15.69% |
| 2022-Q41/3 |
LoseNXGL / S&P -17.22% / 7.56% |
WinNXGL / S&P 32.02% / 11.88% |
LoseNXGL / S&P -41.38% / -17.99% |
| 2022-Q31/3 |
LoseNXGL / S&P -11.18% / -4.88% |
WinNXGL / S&P 83.75% / 13.47% |
LoseNXGL / S&P -34.02% / -1.41% |
| 2022-Q22/3 |
WinNXGL / S&P -11.92% / -16.10% |
WinNXGL / S&P 77.70% / 13.71% |
LoseNXGL / S&P -8.28% / 11.04% |
| 2022-Q11/3 |
LoseNXGL / S&P -26.05% / -4.60% |
WinNXGL / S&P 139.80% / 15.97% |
LoseNXGL / S&P 17.69% / 42.23% |
| 2021-Q41/3 |
LoseNXGL / S&P NXGL unavailable / 11.03% |
WinNXGL / S&P 130.27% / 15.00% |
LoseNXGL / S&P 36.79% / 96.40% |
| 2021-Q31/3 |
LoseNXGL / S&P NXGL unavailable / 0.58% |
WinNXGL / S&P 49.53% / 10.77% |
LoseNXGL / S&P -1485.71% / 69.42% |
| 2021-Q21/3 |
LoseNXGL / S&P NXGL unavailable / 8.55% |
WinNXGL / S&P 29.35% / 6.58% |
LoseNXGL / S&P -1221.43% / 51.81% |
| 2021-Q11/3 |
LoseNXGL / S&P NXGL unavailable / 6.17% |
LoseNXGL / S&P -15.34% / -1.06% |
WinNXGL / S&P 2066.67% / 7.39% |
| 2020-Q41/3 |
LoseNXGL / S&P NXGL unavailable / 12.15% |
LoseNXGL / S&P -6.00% / -3.72% |
WinNXGL / S&P 523.53% / -33.42% |
| 2020-Q30/3 |
LoseNXGL / S&P NXGL unavailable / 8.93% |
LoseNXGL / S&P -25.25% / -2.04% |
LoseNXGL / S&P -129.79% / -27.10% |
| 2020-Q20/3 |
LoseNXGL / S&P NXGL unavailable / 20.54% |
LoseNXGL / S&P -25.31% / -0.46% |
LoseNXGL / S&P -122.95% / -27.11% |
| 2020-Q10/3 |
LoseNXGL / S&P NXGL unavailable / -19.60% |
LoseNXGL / S&P -54.05% / 3.47% |
LoseNXGL / S&P NXGL unavailable / -14.75% |
| 2019-Q40/3 |
LoseNXGL / S&P NXGL unavailable / 9.07% |
LoseNXGL / S&P NXGL unavailable / 5.36% |
LoseNXGL / S&P NXGL unavailable / 2.99% |
| 2019-Q30/3 |
LoseNXGL / S&P NXGL unavailable / 1.70% |
LoseNXGL / S&P NXGL unavailable / 5.02% |
LoseNXGL / S&P NXGL unavailable / 0.21% |
| 2019-Q20/3 |
LoseNXGL / S&P NXGL unavailable / 4.30% |
LoseNXGL / S&P NXGL unavailable / 6.64% |
LoseNXGL / S&P NXGL unavailable / 8.65% |
| 2019-Q10/3 |
LoseNXGL / S&P NXGL unavailable / 13.65% |
LoseNXGL / S&P NXGL unavailable / 8.12% |
LoseNXGL / S&P NXGL unavailable / 14.29% |
| 2018-Q40/3 |
LoseNXGL / S&P NXGL unavailable / -13.52% |
LoseNXGL / S&P NXGL unavailable / 9.05% |
LoseNXGL / S&P NXGL unavailable / 18.23% |
| 2018-Q30/3 |
LoseNXGL / S&P NXGL unavailable / 7.71% |
LoseNXGL / S&P NXGL unavailable / 10.21% |
LoseNXGL / S&P NXGL unavailable / 19.06% |
| 2018-Q20/3 |
LoseNXGL / S&P NXGL unavailable / 3.43% |
LoseNXGL / S&P NXGL unavailable / 9.03% |
LoseNXGL / S&P NXGL unavailable / 14.46% |
| 2018-Q10/3 |
LoseNXGL / S&P NXGL unavailable / -0.76% |
LoseNXGL / S&P NXGL unavailable / 7.68% |
LoseNXGL / S&P NXGL unavailable / 12.46% |
| 2017-Q40/3 |
LoseNXGL / S&P NXGL unavailable / 6.64% |
LoseNXGL / S&P NXGL unavailable / 7.03% |
LoseNXGL / S&P NXGL unavailable / 13.82% |
| 2017-Q30/3 |
LoseNXGL / S&P NXGL unavailable / 4.48% |
LoseNXGL / S&P NXGL unavailable / 5.68% |
LoseNXGL / S&P NXGL unavailable / 17.57% |
| 2017-Q20/3 |
LoseNXGL / S&P NXGL unavailable / 3.09% |
LoseNXGL / S&P NXGL unavailable / 4.83% |
LoseNXGL / S&P NXGL unavailable / 17.74% |
| 2017-Q10/3 |
LoseNXGL / S&P NXGL unavailable / 6.07% |
LoseNXGL / S&P NXGL unavailable / 3.67% |
LoseNXGL / S&P NXGL unavailable / 13.32% |
| 2016-Q40/3 |
LoseNXGL / S&P NXGL unavailable / 3.82% |
LoseNXGL / S&P NXGL unavailable / 2.09% |
LoseNXGL / S&P NXGL unavailable / 7.05% |
| 2016-Q30/3 |
LoseNXGL / S&P NXGL unavailable / 3.85% |
LoseNXGL / S&P NXGL unavailable / 0.20% |
LoseNXGL / S&P NXGL unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | NXGL total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -85.74% | 20.78% |
| Annualized return | -85.74% | 20.78% |
5Y · 2021-12-22 to 2026-08-27
| Metric | NXGL total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -90.06% | 83.14% |
| Annualized return | -36.98% | 12.86% |
10Y · 2021-12-22 to 2026-08-27
| Metric | NXGL total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -90.06% | 319.30% |
| Annualized return | -20.61% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |